Carson Wealth (CWM LLC)
EWTX icon

Carson Wealth (CWM LLC)’s Edgewise Therapeutics EWTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Buy
351
+72
+26% +$2.08K ﹤0.01% 4733
2025
Q4 		$7K Buy
279
+147
+111% +$2.95K ﹤0.01% 4691
2025
Q3 		$2K Buy
132
+23
+21% +$326 ﹤0.01% 4996
2025
Q2 		$1K Buy
109
+48
+79% +$692 ﹤0.01% 4991
2025
Q1 		$1K Buy
61
+35
+135% +$918 ﹤0.01% 4897
2024
Q4 		$1K Buy
26
+6
+30% +$191 ﹤0.01% 4702
2024
Q3 		$1K Buy
20
+15
+300% +$298 ﹤0.01% 4574
2024
Q2 		$0 Buy
5
+2
+67% +$35 ﹤0.01% 4679
2024
Q1 		$0 Buy
+3
New +$48 ﹤0.01% 4438
2023
Q3 		– Sell
-45
Closed – – 4273
2023
Q2 		$0 Buy
+45
New +$380 ﹤0.01% 4247

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EWTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Edgewise Therapeutics (EWTX) stake by 26% in Q1 2026, buying an estimated $2.08K and bringing the position to 351 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4733.

Carson Wealth (CWM LLC) first reported a position in EWTX in Q2 2023 and has held it in 10 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 351 shares of Edgewise Therapeutics worth $11.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 72 Edgewise Therapeutics shares in Q1 2026, an estimated $2.08K.
  • Edgewise Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4733 holding.
  • Carson Wealth (CWM LLC) first reported a position in Edgewise Therapeutics in Q2 2023 and has held it in 10 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.